OğulA. and BüyükşimşekM. (2020) “Prognostic role of inflammatory markers in hepatocellular cancer patients receiving sorafenib therapy”, Medical Science and Discovery, 7(5), pp. 475-481. doi: 10.36472/msd.v7i5.374.